We observed that in patients with ALL as well as in oncogenic FLT3-ITD-positive AML, P2RY14 expression correlated with overall survival where patients carrying the higher expression of P2RY14 had a relatively poor survival (Fig. 2d). The gene discussed is P2RY14; the disease is acute lymphoblastic leukemia.